Search

everythinglearnresearchcommunity

for

Search:↓

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Thyroid receptor β can help develop new drugs to treat hair loss.

Eosinophilic esophagitis may trigger alopecia areata in some patients.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

CAR is a useful marker for assessing alopecia areata severity.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Scientists found a specific group of itch-sensing nerve cells in mice important for feeling itch but not for sensing heat or touch.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Alopecia areata patients have eye issues and need regular eye exams.

Certain drugs can cause early hair growth in mice by affecting the nerves.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

Neurosteroid withdrawal increases α4 subunit expression in the hippocampus, which may relate to catamenial epilepsy in women.

Activin A helps heal skin wounds and protects the brain after injury.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Lower allopregnanolone levels increase stress-related dopamine release in the brain.